Oncolytics Biotech Inc. (ONCY) Social Stream



Oncolytics Biotech Inc. (ONCY): $1.06

0.08 (-7.02%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

Add ONCY to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#147 of 363

in industry

ONCOLYTICS BIOTECH INC (ONCY) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering ONCOLYTICS BIOTECH INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-15 2 $15 $6.72 $10.86 $1.35 704.44%
2022-03-04 1 $15 $6.63 $10.815 $1.35 701.11%
2022-08-18 3 $15 $6.63 $10.815 $1.35 701.11%
2022-11-23 4 $15 $3 $8.21 $1.35 508.15%
2023-03-06 6 $15 $3 $7.81 $1.35 478.52%
2023-06-07 6 $15 $3 $7.248 $1.35 436.89%
2023-08-15 6 $15 $5 $7.648 $1.35 466.52%
2023-11-07 6 $15 $4.62 $7.143 $1.35 429.11%
2023-11-13 6 $6.63 $4.62 $5.25 $1.35 288.89%

The Trend in the Analyst Price Target


ONCY's average price target has moved down $1.48 over the prior 42 months.

ONCY reports an average of 342.57% for its upside potential over the past 36 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-06 6 15 3.00 7.248 1.56 364.62%
2023-03-14 6 15 3.00 7.248 1.30 457.54%
2023-05-08 6 15 3.00 7.248 1.71 323.86%
2023-08-15 6 15 5.00 7.648 2.06 271.26%
2023-11-07 6 15 4.62 7.143 1.60 346.44%

ONCY Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.33 4 2 0 0 0 6

The Trend in the Broker Recommendations


ONCY's average broker recommendation rating worsened by 0.33 over the prior 40 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ONCY as an investment opportunity.

  • ONCY has a higher upside potential (average analyst target price relative to current price) than 1224.07% of all US stocks.
  • ONCOLYTICS BIOTECH INC's average analyst price target is greater than 111.05% of all US stocks.
  • ONCOLYTICS BIOTECH INC's variance in analysts' estimates is lower than -979.85% of all US stocks.
  • ONCOLYTICS BIOTECH INC's number of analysts covering the stock is higher than 273.75% of Healthcare stocks.

In the Pharmaceutical Products industry, CRNX, KZR, and VRCA are the three stocks most similar to ONCOLYTICS BIOTECH INC regarding the price target and analyst recommendation information presented here.

Is ONCY a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!